Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: A case-control study

Sleep

Volumn 34, Issue 10, 2011, Pages 1365-1371

  Palaia, Vincenzo ^a   Poli, Francesca ^a   Pizza, Fabio ^a   Antelmi, Elena ^a   Franceschini, Christian ^a   Moghadam, Keivan Kaveh ^a   Provini, Frederica ^a   Pagotto, Uberto ^b   Montagna, Pasquale ^a   Schenck, Carlos H ^c   Mignot, Emmanuel ^d   Plazzi, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Case control study; Narcolepsy with cataplexy; Nocturnal compulsive behaviors; Nocturnal smoking; Sleep related eating disorder

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CATAPLEXY; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EATING DISORDER; EATING DISORDER INVENTORY 2; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAUDSLEY OBSESSIVE COMPULSIVE INVENTORY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NARCOLEPSY; NOCTURNAL SMOKING; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; SLEEP RELATED EATING DISORDER; SMOKING;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CATAPLEXY; CIRCADIAN RHYTHM; COMPULSIVE BEHAVIOR; EATING DISORDERS; FEMALE; HUMANS; MALE; SMOKING;

EID: 80053514904     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/SLEEP.1280     Document Type: Article

References (53)

1. American Academy of Sleep Medicine. The international classification of sleep disorders, 2nd ed: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
2. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
3. De Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998;95:322-7. (Pubitemid 28103952)
4. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:1 page following 696.
5. Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009;61:162-76.
6. Schenck CH, Hurwitz TD, Bundlie SR, Mahowald MW. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep 1991;14:419-31.
7. Schenck CH, Mahowald MW. Review of nocturnal sleep-related eating disorders. Int J Eat Disord 1994;15:343-56. (Pubitemid 24121743)
8. Vetrugno R, Manconi M, Ferini-Strambi L, Provini F, Plazzi G, Montagna P. Nocturnal eating: sleep-related eating disorder or night eating syndrome? A videopolysomnographic study. Sleep 2006;29:949-54.
9. Provini F, Antelmi E, Vignatelli L, et al. Association of restless legs syndrome with nocturnal eating: a case-control study. Mov Disord 2009;24:871-7.
10. Provini F, Antelmi E, Vignatelli L, et al. Increased prevalence of nocturnal smoking in restless legs syndrome (RLS). Sleep Med 2010;11:218-20.
11. Plazzi G, Ferri R, Antelmi E, et al. Restless legs syndrome is frequent in narcolepsy with cataplexy patients. Sleep 2010;33:689-94.
12. Daniels L. Narcolepsy. Medicine 1934;13:1-122.
13. Kotagal S, Hartse KM, Walsh JK. Characteristics of narcolepsy in preteenaged children. Pediatrics 1990;85:205-9. (Pubitemid 20049422)
14. Challamel MJ, Mazzola ME, Nevsimalova S, Cannard C, Louis J, Revol M. Narcolepsy in children. Sleep 1994;17(8 Suppl):S17-20.
15. Schuld A, Hebebrand J, Geller F, Pollmacher T. Increased body-mass index in patients with narcolepsy. Lancet 2000;355:39-40.
16. Dahmen N, Bierbrauer J, Kasten M. Increased prevalence of obesity in narcoleptic patients and relatives. Eur Arch Psychiatry Clin Neurosci 2001;251:85-9. (Pubitemid 32488036)
17. Kotagal S, Krahn LE, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med 2004;5:147-50. (Pubitemid 38351826)
18. Poli F, Plazzi G, Di Dalmazi G, et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 2009;32:1491-7.
19. Okun ML, Lin L, Pelin Z, Hong S, Mignot E. Clinical aspects of narcolepsy/cataplexy across ethnic groups. Sleep 2002;25:27-35. (Pubitemid 34072656)
20. Chabas D, Foulon C, Gonzalez J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-73. (Pubitemid 47548277)
21. Fortuyn HA, Swinkels S, Buitelaar J, et al. High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep 2008;31:335-41. (Pubitemid 351536505)
22. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19. (Pubitemid 36527231)
23. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-32. (Pubitemid 36527232)
24. Garner DM. Eating disorders inventory-2: professional manual. Odessa, FL: Psychological Assessment Resources, 1991.
25. Hodgson RJ, Rachman S. Obsessional-compulsive complaints. Behav Res Ther 1977;15:389-95. (Pubitemid 8203150)
26. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
27. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
28. Chan DW. The Maudsley Obsessional-Compulsive Inventory: a psychometric investigation on Chinese normal subjects. Behav Res Ther 1990;28:413-20. (Pubitemid 20333694)
29. Støylen IJ, Larsen S, Kvale G. The Maudsley Obsessional-Compulsive Inventory and OCD in a Norwegian nonclinical sample. Scand J Psychol 2000;41:283-6.
30. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck depression inventory: Twenty five years of evalutation. Clin Psychol Rev 1988;8:77-100. (Pubitemid 18045797)
31. Leach C, Lucock M, Barkham M, Stiles WB, Noble R, Iveson S. Transforming between Beck Depression Inventory and CORE-OM scores in routine clinical practice. Br J Clin Psychol 2006;45:153-66. (Pubitemid 43905197)
32. Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005;28:113-21. (Pubitemid 40543126)
33. Roth B, Nevsimalova S. Depression in narcolepsy and hypersomnia. Schweiz Arch Neurol Neurochir Psychiatr 1975;116:291-300.
34. Daniels E, King MA, Smith IE, Shneerson JM. Health-related quality of life in narcolepsy. J Sleep Res 2001;10:75-81. (Pubitemid 32260646)
35. Dauvilliers Y, Paquereau J, Bastuji H, Drouot X, Weil JS, Viot-Blanc V. Psychological health in central hypersomnias: the French Harmony study. J Neurol Neurosurg Psychiatry 2009;80:636-41.
36. Vignatelli L, Plazzi G, Peschechera F, Delaj L, D'Alessandro R. A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med 2010.
37. Spaggiari MC, Granella F, Parrino L, Marchesi C, Melli I, Terzano MG. Nocturnal eating syndrome in adults. Sleep 1994;17:339-44. (Pubitemid 24233996)
38. Perez GA, Haney M, Foltin RW, Hart CL. Modafinil decreases food intake in humans subjected to simulated shift work. Pharmacol Biochem Behav 2008;90:717-22.
39. Malhotra S, King KH, Welge JA, Brusman-Lovins L, McElroy SL. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients. J Clin Psychiatry 2002;63:802-6.
40. McElroy SL, Guerdjikova AI, Winstanley EL, et al. Sodium oxybate in the treatment of binge eating disorder: An open-label, prospective study. Int J Eat Disord 2011;44:262-8.
41. Winkelman JW. Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry 1998;59:14-9. (Pubitemid 28243770)
42. Corrigall WA, Coen KM, Adamson KL. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 1994;653:278-284. (Pubitemid 24252850)
43. Krahn LE, Martin KA, Silber MH. Narcoleptic patients' perceptions of nicotine. J Clin Sleep Med 2009;5:390.
44. Plaza-Zabala A, Martín-García E, De Lecea L, Maldonado R, Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 2010;30:2300-10.
45. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 2001;24:429-58. (Pubitemid 32695235)
46. Peyron C, Tighe DK, Van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015. (Pubitemid 28543775)
47. Date Y, Ueta Y, Yamashita H, et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 1999;96:748-53. (Pubitemid 29061280)
48. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999;827:243-60. (Pubitemid 29222929)
49. Elias CF, Saper CB, Maratos-Flier E, et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 1998;402:442-59. (Pubitemid 29001074)
50. Yoshida K, McCormack S, España RA, Crocker A, Scammell TE. Afferents to the orexin neurons of the rat brain. J Comp Neurol 2006;494:845-61. (Pubitemid 43054230)
51. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001;24:726-31. (Pubitemid 33097540)
52. Schenck CH, Hurwitz TD, O'Connor KA, Mahowald MW. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep 1993;16:457-66. (Pubitemid 23241669)
53. Provini F, Albani F, Vetrugno R, et al. A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. Eur J Neurol 2005;12:432-6. (Pubitemid 40768661)